Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew E Witek

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Head & Neck|December 23, 2024
Comprehensive Analysis Reveals No Significant Correlation Between p16/ CDKN2A Expression and Treatment Outcomes in Laryngeal Squamous Cell CarcinomaHelen Hieu Nguyen, Ishita Gupta, Ashley Cellini, et al.
Practical Radiation Oncology|November 20, 2014
Optimizing patient positioning for intensity modulated radiation therapy in hippocampal-sparing whole brain radiation therapyJoshua Siglin, Colin E Champ, Yelena Vakhnenko, et al.
Journal of Clinical Imaging Science|October 9, 2023
Post-treatment PET/CT for p16-positive oropharynx cancer treated with definitive proton therapyGregory S Alexander, Ariel Eve Pollock, Danielle Arons, et al.
Head & Neck|March 1, 2023
Multi-institutional study of clinical outcomes of patients with head and neck cancer presenting with cN3 diseaseMatthew E Witek, Christopher G Morris, Gregory S Alexander, et al.
Plos One|August 8, 2014
A novel CDX2 isoform regulates alternative splicingMatthew E Witek, Adam E Snook, Jieru E Lin, et al.
Otorhinolaryngology-Head and Neck Surgery|October 2, 2018
HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patientsAdam R Burr, Paul M Harari, Huaising C Ko, et al.
Journal of Applied Clinical Medical Physics|July 14, 2025
Optimizing quality assurance CT schedules during adaptive proton therapy for enhanced patient careNrusingh C Biswal, Mark J Zakhary, Abdul K Parchur, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 20, 2017
Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic LarynxHuaising C Ko, Paul M Harari, Shuai Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancerStephanie Schulz, Terry Hyslop, Janis Haaf, et al.
Head & Neck|July 25, 2017
Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer DatabaseHuaising C Ko, Shuai Chen, Aaron M Wieland, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Head & Neck|December 23, 2024
Comprehensive Analysis Reveals No Significant Correlation Between p16/ CDKN2A Expression and Treatment Outcomes in Laryngeal Squamous Cell CarcinomaHelen Hieu Nguyen, Ishita Gupta, Ashley Cellini, et al.
Practical Radiation Oncology|November 20, 2014
Optimizing patient positioning for intensity modulated radiation therapy in hippocampal-sparing whole brain radiation therapyJoshua Siglin, Colin E Champ, Yelena Vakhnenko, et al.
Journal of Clinical Imaging Science|October 9, 2023
Post-treatment PET/CT for p16-positive oropharynx cancer treated with definitive proton therapyGregory S Alexander, Ariel Eve Pollock, Danielle Arons, et al.
Head & Neck|March 1, 2023
Multi-institutional study of clinical outcomes of patients with head and neck cancer presenting with cN3 diseaseMatthew E Witek, Christopher G Morris, Gregory S Alexander, et al.
Plos One|August 8, 2014
A novel CDX2 isoform regulates alternative splicingMatthew E Witek, Adam E Snook, Jieru E Lin, et al.
Otorhinolaryngology-Head and Neck Surgery|October 2, 2018
HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patientsAdam R Burr, Paul M Harari, Huaising C Ko, et al.
Journal of Applied Clinical Medical Physics|July 14, 2025
Optimizing quality assurance CT schedules during adaptive proton therapy for enhanced patient careNrusingh C Biswal, Mark J Zakhary, Abdul K Parchur, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 20, 2017
Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic LarynxHuaising C Ko, Paul M Harari, Shuai Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancerStephanie Schulz, Terry Hyslop, Janis Haaf, et al.
Head & Neck|July 25, 2017
Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer DatabaseHuaising C Ko, Shuai Chen, Aaron M Wieland, et al.
Pageof 5